2:0
Best of 3February 13 - 6:00 PM
_1739735713548.png)
Best of 3
Map veto
| # | Action | Map | Team |
|---|---|---|---|
| 1 | Ban | Bind | Ingenious Esports |
| 2 | Ban | Haven | Esports Cologne Eiskalt |
| 3 | Pick | Corrode | Ingenious Esports |
| 4 | Pick | Breeze | Esports Cologne Eiskalt |
| 5 | Ban | Split | Ingenious Esports |
| 6 | Ban | Abyss | Esports Cologne Eiskalt |
| 7 | Dec | Pearl |
VODs
No VODs available
Community predictions
Voting ClosedEsports Cologne Eiskalt100% (2 votes)Ingenious Esports0% (0 votes)| Esports Cologne Eiskalt | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.49 | 314 | 51 | 34 | 9 | +17 | 1.50 | 76.1% | 208.8 | 33% | 7 | 6 | |
| 1.04 | 226 | 36 | 31 | 8 | +5 | 1.16 | 76.1% | 148.3 | 33% | 5 | 3 | |
| 0.92 | 188 | 32 | 30 | 5 | +2 | 1.07 | 69.6% | 122.3 | 21% | 6 | 4 | |
| 0.85 | 166 | 27 | 31 | 12 | −4 | 0.87 | 71.7% | 109.6 | 33% | 5 | 3 | |
| 0.71 | 147 | 22 | 28 | 10 | −6 | 0.79 | 76.1% | 96.7 | 24% | 2 | 5 |
| Ingenious Esports | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.39 | 263 | 47 | 30 | 9 | +17 | 1.57 | 67.4% | 160.5 | 21% | 3 | 2 | |
| 1.01 | 229 | 31 | 34 | 19 | −3 | 0.91 | 78.3% | 163.4 | 13% | 3 | 3 | |
| 0.94 | 208 | 32 | 37 | 12 | −5 | 0.86 | 73.9% | 137.8 | 29% | 5 | 8 | |
| 0.77 | 172 | 25 | 33 | 12 | −8 | 0.76 | 67.4% | 115.9 | 29% | 5 | 5 | |
| 0.50 | 109 | 19 | 34 | 6 | −15 | 0.56 | 58.7% | 76.2 | 25% | 5 | 7 |
Previous matches
| Date | Opponent | Score |
|---|---|---|
| February 11, 2026 | 0:2 | |
| February 6, 2026 | 2:1 | |
| November 9, 2025 | 0:0 | |
| November 9, 2025 | 0:0 |
_1743846742576.png "Glacial Guardians"){kind=small}
| Date | Opponent | Score |
|---|---|---|
| February 11, 2026 | 2:1 | |
| February 6, 2026 | 1:2 | |
| January 4, 2026 | 0:1 | |
| January 4, 2026 | 1:0 |
_1750069768543.png "Entropy"){kind=small}
_1737777359039.png "TeamOrangeGaming"){kind=small}
_1744018383331.png "TOG Inari"){kind=small}
Head to head
0
wins0
draws0
winsNo previous head-to-head matches
Match discussion
0 commentsNo comments yet. Be the first to start the discussion.